PBS updates

DBL Bortezomib (Bortezomib)

bortezomib 3 mg injection, 1 vial · INJECTION · PBS code 12227M

RESTRICTED

What it costs

AU$286.63 PBS-determined price per pack

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2022-02-01.
  • • Repeats: 15.
  • • PBS program: IP.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Multiple myeloma

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Newly diagnosed systemic light chain amyloidosis


Administration on Days 1, 8, 15 and 22 of six treatment cycles (28 days per cycle) in total


Patient must be undergoing concurrent treatment with PBS-subsidised daratumumab for this PBS indication.

Sponsor: Pfizer Australia Pty Ltd ABN 50 008 422 348

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.